RT Journal Article
SR Electronic
T1 Mapping the Burden of COVID-19 in the United States
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.05.20054700
DO 10.1101/2020.04.05.20054700
A1 Miller, Ian F.
A1 Becker, Alexander D.
A1 Grenfell, Bryan T.
A1 Metcalf, C. Jessica E.
YR 2020
UL http://medrxiv.org/content/early/2020/04/11/2020.04.05.20054700.abstract
AB As of April 5th 2020, SARS-CoV-2 has resulted in over 273,000 confirmed infections in the United States of America. Incidence continues to rise. As the epidemic threatens to overwhelm health care systems, identifying regions where the expected disease burden is likely to be high relative to the rest of the country is critical for enabling prudent and effective distribution of emergency resources. Across all global regions affected by the pandemic, an elevated risk of severe outcomes has consistently been observed in older age groups. Using age-specific mortality patterns in tandem with demographic data, we map a projection of the cumulative burden of COVID-19 and the associated cumulative burden on the healthcare system at the county-scale in the United States for a scenario in which 20% of the population of each county acquires infection. We identify regions that may be particularly impacted relative to the rest of the country, and observe a general trend that per capita disease burden and relative healthcare system demand may be highest away from major population centers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementI.F.M and A.D.B. acknowledge funding from National Science Foundation Graduate Research Fellowships.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode and data associated with the analyses are available via github. https://github.com/ianfmiller/covid19-burden-mapping